First Vietnamese COVID-19 vaccine Nano Covax enters second phase of human trials

February 28, 2021 | 11:00
The second phase of human trials for the first domestically-made COVID-19 vaccine Nano Covax began on February 26, as the next step in Vietnam’s vaccine development. Developed by Nanogen Pharmaceutical Biotechnology JSC, Nano Covax is anticipated to begin its third phase in May, and will be hopefully available in the market next year, helping the country control its vaccine supply and ease reliance on imports.
first vietnamese covid 19 vaccine nano covax enters second phase of human trials
first vietnamese covid 19 vaccine nano covax enters second phase of human trials
first vietnamese covid 19 vaccine nano covax enters second phase of human trials
first vietnamese covid 19 vaccine nano covax enters second phase of human trials
first vietnamese covid 19 vaccine nano covax enters second phase of human trials
first vietnamese covid 19 vaccine nano covax enters second phase of human trials
first vietnamese covid 19 vaccine nano covax enters second phase of human trials
first vietnamese covid 19 vaccine nano covax enters second phase of human trials
first vietnamese covid 19 vaccine nano covax enters second phase of human trials
first vietnamese covid 19 vaccine nano covax enters second phase of human trials
Photo Bich Van

By Bich Thuy

What the stars mean:

★ Poor ★ ★ Promising ★★★ Good ★★★★ Very good ★★★★★ Exceptional